In this study, we examined the interplay of selected genetic polymorphisms (in CTLA-4, FOXO-3, and PTPN-22) with AITD, MASLD, probiotics, and vitamin D supplementation and stress exposure in a cohort of patients with T1D. The gene discussed is PTPN22; the disease is type 1 diabetes mellitus.